Rapid molecular tests for tuberculosis and tuberculosis drug resistance: a qualitative evidence synthesis of recipient and provider views

N Engel, EA Ochodo, PW Karanja… - Cochrane Database …, 2022 - cochranelibrary.com
Background Programmes that introduce rapid molecular tests for tuberculosis and
tuberculosis drug resistance aim to bring tests closer to the community, and thereby cut …

Systematic review, meta-analysis and economic modelling of molecular diagnostic tests for antibiotic resistance in tuberculosis.

F Drobniewski, M Cooke, J Jordan… - Health technology …, 2015 - researchonline.lshtm.ac.uk
BACKGROUND: Drug-resistant tuberculosis (TB), especially multidrug-resistant (MDR,
resistance to rifampicin and isoniazid) disease, is associated with a worse patient outcome …

Impact of molecular diagnostics for tuberculosis on patient-important outcomes: a systematic review of study methodologies

SG Schumacher, H Sohn, ZZ Qin, G Gore, JL Davis… - PLoS …, 2016 - journals.plos.org
Background Several reviews on the accuracy of Tuberculosis (TB) Nucleic Acid
Amplification Tests (NAATs) have been performed but the evidence on their impact on …

Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms

AE Shapiro, JM Ross, M Yao, I Schiller… - Cochrane Database …, 2021 - cochranelibrary.com
Background Tuberculosis is a leading cause of infectious disease‐related death and is one
of the top 10 causes of death worldwide. The World Health Organization (WHO) …

The Global Consortium for Drug-resistant Tuberculosis Diagnostics (GCDD): design of a multi-site, head-to-head study of three rapid tests to detect extensively drug …

N Hillery, EJ Groessl, A Trollip, D Catanzaro, L Jackson… - Trials, 2014 - Springer
Background Drug-resistant tuberculosis (DR-TB) remains a threat to global public health,
owing to the complexity and delay of diagnosis and treatment. The Global Consortium for …

[HTML][HTML] The impact of the roll-out of rapid molecular diagnostic testing for tuberculosis on empirical treatment in Cape Town, South Africa

S Hermans, J Caldwell, R Kaplan… - Bulletin of the World …, 2017 - ncbi.nlm.nih.gov
Objective To investigate the impact of introducing a rapid test as the first-line diagnostic test
for drug-sensitive tuberculosis in Cape Town, South Africa. Methods Xpert® MTB/RIF …

Rapid molecular assays for the diagnosis of drug-resistant tuberculosis

L Nandlal, R Perumal, K Naidoo - Infection and Drug Resistance, 2022 - Taylor & Francis
The recognition that drug-resistant tuberculosis (DR-TB) poses a major threat to global
tuberculosis (TB) control efforts has catalysed the development of new and urgently needed …

Comparison of laboratory costs of rapid molecular tests and conventional diagnostics for detection of tuberculosis and drug-resistant tuberculosis in South Africa

M Shah, V Chihota, G Coetzee, G Churchyard… - BMC infectious …, 2013 - Springer
Abstract Background The World Health Organization has endorsed the use of molecular
methods for the detection of TB and drug-resistant TB as a rapid alternative to culture-based …

Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin

GR Davies, M Chaplin, M De Vos… - Cochrane Database …, 2022 - cochranelibrary.com
Background The World Health Organization (WHO) End TB Strategy stresses universal
access to drug susceptibility testing (DST). DST determines whether Mycobacterium …

[图书][B] WHO consolidated guidelines on tuberculosis. Module 3: diagnosis–rapid diagnostics for tuberculosis detection

World Health Organization - 2024 - books.google.com
The “WHO consolidated guidelines on tuberculosis. Module 3: Diagnosis-Rapid diagnostics
for tuberculosis detection, third edition” is the latest document replacing the one issued in …